The acquisition of Cytozyme Laboratories has opened up the opportunity to provide the most advanced nutrient use efficiency products to farmers
The Verdesian Life Sciences acquisition of Cytozyme Laboratories in April 2021 continues to show positive momentum. While the acquisition of Cytozyme made sense from a cultural and product mix standpoint, it also opened up the opportunity to provide the most advanced nutrient use efficiency products to farmers in parts of the world that were not privy to them previously. One of those key areas is India.
“International expansion is a top priority. Cytozyme’s global presence and long-standing partnerships filled strategic geographic needs,” said Rick Riegner, Executive VP, Strategy & Business Development. “The acquisition provided us an intact, highly-motivated Indian team, accelerating efforts to commercialise the broader Verdesian portfolio across India.”
RK Goyal, Business Director in South Asia said, “We will be able to offer our Indian growers new Verdesian technologies that will allow them to get the most out of their crops. Growers here are passionate about sustainable agriculture, and our growing product mix goes a long way in helping us all accomplish that.”
Since April, the Verdesian India team has been able to introduce four new products to growers in the country. These are AVAIL – Phosphorus Fertilizer Enhancer; NutriSphere-N – Nitrogen Fertilizer Manager; Primacy ALPHA – Foliar and Soil Nutrient and Take Off ST – Seed Treatment.
